Suppr超能文献

相似文献

1
Exosomes as diagnostic and predictive biomarkers in lung cancer.
J Thorac Dis. 2017 Oct;9(Suppl 13):S1373-S1382. doi: 10.21037/jtd.2017.10.67.
2
Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer.
Cancer Med. 2020 Oct;9(19):6909-6922. doi: 10.1002/cam4.3379. Epub 2020 Aug 10.
4
PLA2G10 incorporated in exosomes could be diagnostic and prognostic biomarker for non-small cell lung cancer.
Clin Chim Acta. 2022 May 1;530:55-65. doi: 10.1016/j.cca.2022.02.016. Epub 2022 Feb 26.
5
Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Oncotarget. 2017 Feb 21;8(8):13048-13058. doi: 10.18632/oncotarget.14369.
6
MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Eur Urol Focus. 2018 Apr;4(3):412-419. doi: 10.1016/j.euf.2016.09.007. Epub 2016 Oct 14.
7
Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Clin Transl Oncol. 2017 Jun;19(6):651-657. doi: 10.1007/s12094-016-1599-5. Epub 2017 Jan 4.
8
The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer.
Expert Rev Mol Diagn. 2015;15(9):1159-69. doi: 10.1586/14737159.2015.1069183. Epub 2015 Jul 22.
9
Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer.
Mol Cancer. 2022 Feb 16;21(1):54. doi: 10.1186/s12943-022-01525-9.
10
Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer.
Cancer Gene Ther. 2017 Feb;24(2):48-56. doi: 10.1038/cgt.2016.77. Epub 2016 Dec 16.

引用本文的文献

1
Intratumoral heterogeneity and drug resistance in cancer.
Cancer Cell Int. 2025 Mar 18;25(1):103. doi: 10.1186/s12935-025-03734-w.
2
Innovative approaches in lung tissue engineering: the role of exosome-loaded bioscaffolds in regenerative medicine.
Front Bioeng Biotechnol. 2024 Dec 20;12:1502155. doi: 10.3389/fbioe.2024.1502155. eCollection 2024.
3
The Role of Induced Pluripotent Stem Cells in the Treatment of Stroke.
Curr Neuropharmacol. 2024;22(14):2368-2383. doi: 10.2174/1570159X22666240603084558.
4
Clinical applications of circulating biomarkers in non-small cell lung cancer.
Front Cell Dev Biol. 2024 Aug 21;12:1449232. doi: 10.3389/fcell.2024.1449232. eCollection 2024.
5
Liquid biopsy for early detection of lung cancer.
Chin Med J Pulm Crit Care Med. 2023 Oct 20;1(4):200-206. doi: 10.1016/j.pccm.2023.08.005. eCollection 2023 Dec.
7
Small Extracellular Vesicles Harboring PD-L1 in Obstructive Sleep Apnea.
Int J Mol Sci. 2024 Mar 11;25(6):3208. doi: 10.3390/ijms25063208.
9
Epigenetic regulation in lung cancer.
MedComm (2020). 2023 Oct 26;4(6):e401. doi: 10.1002/mco2.401. eCollection 2023 Dec.

本文引用的文献

1
The biology, function and clinical implications of exosomes in lung cancer.
Cancer Lett. 2017 Oct 28;407:84-92. doi: 10.1016/j.canlet.2017.08.003. Epub 2017 Aug 12.
3
MicroRNA: A novel target of curcumin in cancer therapy.
J Cell Physiol. 2018 Apr;233(4):3004-3015. doi: 10.1002/jcp.26055. Epub 2017 Aug 3.
6
Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer.
Oncol Lett. 2017 Mar;13(3):1256-1263. doi: 10.3892/ol.2017.5569. Epub 2017 Jan 4.
7
Progress in Exosome Isolation Techniques.
Theranostics. 2017 Jan 26;7(3):789-804. doi: 10.7150/thno.18133. eCollection 2017.
8
Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Oncotarget. 2017 Feb 21;8(8):13048-13058. doi: 10.18632/oncotarget.14369.
9
Exosomal proteins as prognostic biomarkers in non-small cell lung cancer.
Mol Oncol. 2016 Dec;10(10):1595-1602. doi: 10.1016/j.molonc.2016.10.003. Epub 2016 Oct 21.
10
Tumor-Derived Exosomes and Their Role in Tumor-Induced Immune Suppression.
Vaccines (Basel). 2016 Oct 20;4(4):35. doi: 10.3390/vaccines4040035.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验